Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: FranciaországFázis nélkül

Multimodal Electrophysiological Study of Cortico-subcortical Biomarkers of Tics in Tourette Syndrome

A legfontosabb adatok

Ki végzi
University Hospital, Bordeaux
Hol
Bordeaux (Franciaország)A helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
10 fő, tervezett
Kezdés
2025. febr. 17.
Várható befejezés
2027. febr. 17.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Multimodal electrophysiological recordings
A regiszteradat frissítve
2025. április 3.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for people with severe Tourette syndrome that drugs have not helped. They must already have deep brain stimulation with a PERCEPT™ device as part of their usual care.

Életkor
16 years and older.
Nem
All sexes can join.
A betegség stádiuma
Disabling Tourette syndrome that does not respond to drugs.
Korábbi kezelés
Must be receiving deep brain stimulation, with the PERCEPT™ device implanted as part of their medical care.
Biomarker vagy leletérték
A normal brain MRI scan.

A részvétel fő kizáró okai

  • Major depression (Beck Depression Inventory (BDI-II) score > 20).
  • MRI showing marked brain shrinkage or marked bright spots (hyperintensities).
  • Pregnant or breastfeeding.
  • Unable to give consent, or under legal guardianship or court protection.
  • Taking part in another study that does not allow joining other research.

A regiszter feltételei, szó szerint

Mind a 12 feltétel megnézéseKevesebb

Ki vehet részt

  • Patient at least 16 years old
  • Disabling and drug-resistant Tourette's syndrome
  • Receiving deep brain stimulation treatment with implantation of the PERCEPT™ Device as part of their medical management
  • Normal brain MRI
  • Subject affiliated or beneficiary of a social security system
  • Free and informed consent of the patient and, for minors, of the minor and at least one parental authority

Ki nem vehet részt

  • Major depressive syndrome (Beck Depression Inventory (BDI-II) > 20)
  • MRI showing significant brain atrophy or significant hyperintensities
  • Pregnant or nursing mothers
  • Person unable to give personal consent
  • Person subject to a legal protection measure (curatorship, guardianship) or placed under court protection
  • Patient included in another research protocol with an interdiction of participation to another research or in an exclusion period

Ez a vizsgálat jelenleg itt érhető el: Franciaország.

  • CHU de BordeauxBordeaux, FranciaországContact: Edouard COURTIN, DrRésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

Tourette syndrome (TS) is a complex neurodevelopmental disorder characterized by the occurrence of involuntary movements (motor tics) and vocalizations (phonic tics). The onset of TS is usually in childhood, and the prevalence of TS is estimated between 0.3 and 0.9% before the age of 18, decreasing progressively after that age. Most patients also suffer from associated psychiatric comorbidities (ADHD, OCD, mood disorders). Although the cause of TS remains unknown, the preferred hypothesis is the interaction of predisposing genetic factors and precipitating environmental factors (perinatal accidents, infectious diseases). From a pathophysiological point of view, it is widely demonstrated by structural, electrophysiological studies, functional neuroimaging, as well as by different animal models, that dysfunctions of the cortico-striato-pallido-thalamo-cortical loops (responsible for the regulation of movements, cognitive processes, and emotions) play a major role in the genesis of tics. Deep brain stimulation (DBS) treatment can be proposed as an invasive therapy in patients with severe TS resistant to usual treatments (psychotherapy, pharmacological treatments). In a well-selected population of drug-resistant patients, DBS allows an estimated overall improvement of 30 to 50% in the YGTSS score. The deep brain stimulation method currently used in TS is based on continuous (24/7) and undifferentiated stimulation (fixed electrical intensity). This stimulation paradigm, devoid of adaptability to the patient's symptoms, could be at the origin of undesirable effects (related to the modulation of physiological signals), of a sub-optimal efficiency, or of an unnecessary overuse of the stimulator's capacities (battery depletion). The development of new deep brain stimulation paradigms ("closed-loop stimulation"), allowing the identification of pathological neuronal activity and the dynamic adaptation of stimulation parameters to these neuronal signals, requires reliable and reproducible pathological biomarker, correlated with the occurrence of tics.

A teljes eredeti leírásKevesebb

However, in TS, electrophysiological abnormalities are still not well characterized, and most of the work published on the subject were based on intraoperative recordings and needs to be confirmed on recordings at a distance from the surgery before its potential use in closed-loop stimulation paradigms. Indeed, during the first weeks after surgery, different factors tend to modify the electrophysiological signals.

Several questions arise at the end of this healing period:

* Are these pathological oscillations (distinct from the brain oscillations induced by physiological voluntary movement) still detectable weeks after the surgery? * What are the temporal dynamics of these oscillations around a tic? * What is the spatial topography of these oscillations within the GPi? * Is there a strong inter-individual variability? * How are changes in cortical activity associated with these subcortical oscillations? * Are the modulations of pallidal activity alone sufficient to predict the occurrence of a tic? Thus, our study aims to define precisely the cortico-subcortical activity concomitant with the occurrence of a tic, and to identify reliable and reproducible biomarker(s) associated with tics in TS.

In order to specify these biomarker(s), their temporal correlation to tic occurrence, their spatial distribution, as well as the dynamics and cortico-subcortical coherence of the identified abnormalities, we propose a prospective study on 10 patients with severe and drug-resistant TS, treated by bi-pallidal deep brain stimulation as part of routine care (no device implantation as part of the research).

An evaluation of pallidal LFP synchronized with a high-resolution video-electroencephalography recording (128 to 256 sensors) will be performed at a distance (M+[3-48]) from surgery, in order to determine the variations in pallidal and electroencephalographic activity surrounding the occurrence of tics. A control condition with voluntary ("tic-like") movement will be carried out in a second time, to distinguish the modifications related to the voluntary movement from those related to the occurrence of a tic. A reconstruction of the electrode positioning will be performed using the LeadDBS pipeline, and individual and group analyses will be performed to specify the mapping of pathological oscillations within the pallidum and throughout the cerebral cortex.

A vizsgálat csoportja

  • Patient with Tourette's syndromeA vizsgált kezelés

    Patient with Tourette's syndrome receiving deep brain stimulation treatment with implantation of the PERCEPT™ device as part of their medical management.

    Kezelés: Multimodal electrophysiological recordings

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2025. április 3.